SCHEMBL6401147

SCHEMBL6401147

CN(CCO)CC(=O)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.59
KDM4E B2RXH2 4/20 0.51
ALDH1A1 P00352 3/20 0.51
USP2 O75604 1/20 0.51
MAPT P10636 3/20 0.47
TDP1 Q9NUW8 3/20 0.47
MEN1 O00255 3/20 0.47
MAPK1 P28482 2/20 0.47
CYP3A4 P08684 2/20 0.47
ALOX15 P16050 2/20 0.47
HPGD P15428 1/20 0.47
CES1 P23141 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
L3MBTL1 Q9Y468 4/20 0.45
AGTR1 P30556 1/20 0.45
GSK3B P49841 2/20 0.44
PTPN1 P18031 2/20 0.44
HIF1A Q16665 2/20 0.44
TRPA1 O75762 1/20 0.44
EGFR P00533 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12352714 0.85 KMT2A (0.59) KMT2AKDM4EALDH1A1USP2MAPT
SCHEMBL7472642 0.84 KMT2A (0.68) KMT2AKDM4EALDH1A1USP2MAPT
SCHEMBL6398922 0.84 KMT2A (0.58) KMT2AKDM4EALDH1A1USP2MAPT
SCHEMBL10749154 0.82 HPGD (0.47) KMT2AKDM4EMAPTTDP1MEN1
SCHEMBL28159725 0.81 KMT2A (0.58) KMT2AKDM4EALDH1A1USP2MAPT
SCHEMBL25576274 0.81 KMT2A (0.58) KMT2AKDM4EALDH1A1USP2MAPT
Benzophenone SCHEMBL2321915 0.81 KMT2A (0.58) KMT2AKDM4EALDH1A1TDP1MEN1
SCHEMBL27781077 0.80 PTPN1 (0.53) KDM4EALDH1A1HPGDCES1SMN1; SMN2
SCHEMBL10887429 0.80 ALDH1A1 (0.55) KMT2AKDM4EALDH1A1USP2MAPT
SCHEMBL6403381 0.79 KMT2A (0.56) KMT2AKDM4EALDH1A1USP2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119176757-A Preparation method of mianserin hydrochloride intermediate and derivative thereof 四川青木制药有限公司 2024-12-24 CN disclosed
US-20050004092-A1 Penem derivatives and antimicrobial agent containing the same DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2005-01-06 US disclosed
EP-0757051-B1 PENEM DERIVATIVES AND ANTIMICROBIAL AGENT CONTAINING THE SAME DAIICHI SUNTORY PHARMA CO LTD (JP) 2003-10-29 EP disclosed
EP-0757051-A1 PENEM DERIVATIVES AND ANTIMICROBIAL AGENT CONTAINING THE SAME SUNTORY LIMITED (JP) 1997-02-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004092-A1 Penem derivatives and antimicrobial agent containing the same MRPL21, MRPS2, MRPS28 KMT2A 2222/4885KDM4E 1902/4885ALDH1A1 1862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.